• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.79% Nasdaq Up 0.16%

    Curis, Inc. (CRIS)

    -NasdaqGM
    1.67 Down 0.01(0.60%) Jan 23, 4:00PM EST
    Add to Portfolio
    Prev Close:1.68
    Open:1.70
    Bid:1.67 x 500
    Ask:2.50 x 300
    1y Target Est:5.00
    Beta:0.99
    Earnings Date:Feb 18 - Feb 23 (Est.)
    Day's Range:1.60 - 1.71
    52wk Range:1.09 - 3.40
    Volume:921,607
    Avg Vol (3m):481,089
    Market Cap:143.63M
    P/E (ttm):N/A
    EPS (ttm):-0.20
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CRIS

    Comparison

    Symbol% ChgMkt Cap
    CRISDown 0.60%143.63M
    EXELUp 0.62%318.20M
    INFIUp 3.80%745.63M
    PFEDown 1.10%204.46B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):15.41
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.22
    Quarterly EPS Est (Dec-14) :-0.07
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Curis, Inc. is engaged in the research, development, and commercialization of cancer therapeutics. It focuses on developing cancer drug candidates, including CUDC-907, an oral, small molecule drug candidate that is designed to inhibit histone deac... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback